Ryght AI and QPS have announced a strategic partnership to enhance clinical trial processes globally. QPS has selected Ryght AI as its exclusive AI partner, aiming to optimize and automate clinical trials. This collaboration will integrate QPS's extensive network of research sites into the Ryght Research Network, significantly expanding capabilities.
The partnership combines Ryght AI's advanced generative AI technology with QPS's vast clinical trial experience. It addresses critical challenges in the clinical research sector, such as communication inefficiencies and delays in therapy development. By leveraging AI, the alliance aims to streamline workflows and accelerate the delivery of new therapies to patients.
• Ryght AI selected as exclusive AI partner for QPS's clinical trials.
• Partnership aims to streamline clinical trial processes using generative AI.
In this partnership, Ryght AI's generative AI capabilities will enhance real-time decision-making in clinical trials.
The partnership focuses on optimizing these trials to improve efficiency and speed in bringing therapies to market.
Ryght AI specializes in generative AI solutions for the clinical research industry, enhancing trial management and communication.
QPS is a global contract research organization that provides comprehensive services for clinical trials, leveraging its extensive site network.
YAHOO!Finance 9month
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.